Encompass Health vs Summit Therapeutics
Encompass Health (EHC), health care, and Summit Therapeutics (SMMT), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Encompass Health is worth $13.5B on the stock market and Summit Therapeutics $8.5B: Encompass Health is valued at 59% more. Over the past year Encompass Health's share price has moved +26.1% and Summit Therapeutics's -29.7%.
Key facts
- Encompass Health market value
- $13.5B
- Summit Therapeutics market value
- $8.5B
- Encompass Health P/E
- 22.8
- Encompass Health revenue
- $5.9BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Encompass Health | Summit Therapeutics |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $13.5Bhigher | $8.5Blower |
| Revenue | $5.9B | — |
| Earnings | $566.2Mhigher | -$1.1Blower |
| Employees | 29,875higher | 265lower |
| Total assets | $7.1Bhigher | $751.2Mlower |
| Valuation | ||
| P/E | 22.8 | — |
| P/S | 2.3 | — |
| P/B | 5.1lower | 15.1higher |
| Dividend yield | 0.55%higher | 0.00%lower |
| Profitability | ||
| Operating margin | — | — |
| Balance sheet | ||
| Net assets | $2.4Bhigher | $658.9Mlower |
| Total liabilities | $3.8Bhigher | $92.3Mlower |
| Total debt | $2.5B | — |
| Cash on hand | $72.2Mlower | $225.3Mhigher |
| Price change | ||
| Today | -2.98%higher | -9.73%lower |
| 1 year | +26.1%higher | -29.7%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Encompass Health only (4)
- Brandon Haley0.2%
- Fred DiSanto0.2%
- Ken Griffin0.1%
- Jensen team0.1%
Summit Therapeutics only (1)
Percentages are each holding's share of that investor's reported portfolio. Who owns EHC · Who owns SMMT
More on Encompass Health
Further comparisons
Encompass Health against its closest peers
Summit Therapeutics against its closest peers
Learn
Questions and answers
Which is bigger, Encompass Health or Summit Therapeutics?
By market value, Encompass Health is the larger: $13.5B against $8.5B for Summit Therapeutics.
Which has the higher dividend yield?
Encompass Health: 0.55%, against 0.00% for Summit Therapeutics. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Encompass Health and Summit Therapeutics?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Encompass Health and 1 holds Summit Therapeutics.
Cite this page
Funkfolio, “Encompass Health vs Summit Therapeutics”, data as of 18 November 2026. https://funkfolio.com/compare/ehc-vs-smmt
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.